Tilray Brands Inc. Common Stock (TLRY)

FairStock Score: 52/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Tilray as a Graham-style analyst: I want a durable business, honest earnings, and a margin of safety. Here I see a consumer-products and cannabis company with four segments and a $483.3M market cap at the 2026-10-13 close. Revenue has grown: FY2024 $788.9M, FY2025 $821.3M, FY2026 $915.5M. But the bottom line is not there. FY2024 net loss was $245.0M, FY2025 was $2.2B, and FY2026 was $121.4M. In fiscal Q1 2027, the quarter ended 2026-08-31, revenue was $257.1M and net loss was $43.1M. That is not a business funding itself; trailing free cash flow is -$102.1M, a -21.1% FCF yield. FairStock ratios show P/B 1.08, ROE -6.82%, ROCE -1.49%, Piotroski 3/9, Altman Z -2.25, and EV/EBITDA 69.36. The Lynch screen finds no category because it lost money in each of the last four years. The balance sheet has D/E 0.25, so debt is not extreme, but weak returns and cash burn still erode value. The stock sits near its 52-week low of $3.25 against a high of $16.90, which may attract bargain hunters, but a low price without earnings is not the same as cheap. I see no durable moat in regulated, fragmented cannabis, and the company must prove it can generate consistent profit and cash before the shares deserve a value investor's confidence. FairStock Score is 52/100.

In plain English: Tilray Brands sells cannabis, drinks, and wellness products in several countries. Sales are growing, but the company still loses money and uses more cash than it brings in. The share price is near its lowest level of the past year, but because there are no profits, it does not look clearly cheap based on the numbers shown.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2027 10-Q (period ended 2026-08-31) · fiscal Q3 2026 10-Q (period ended 2026-02-28) · fiscal Q2 2026 10-Q (period ended 2025-11-30) · fiscal Q1 2026 10-Q (period ended 2025-08-31) · FY2026 10-K (period ended 2026-05-31) · FY2025 10-K (period ended 2025-05-31) · FY2024 10-K (period ended 2024-05-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer